Sonnet BioTherapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Segments of Business - Schedule of Revenues and Operating Income (loss) by Segment (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenue	$ 9,859,997	$ 10,111,776
Operating Income (Loss):	(989,388)	(906,083)
Depreciation and Amortization	593,380	570,440
Operating Segments [Member]
Revenue	9,859,997	10,111,776
Operating Income (Loss):	(989,388)	(906,083)
Depreciation and Amortization	593,380	570,440
Operating Segments [Member] \| Hooters Full Service [Member]
Revenue	3,135,463	3,173,912
Operating Income (Loss):	(42,846)	50,820
Depreciation and Amortization	136,180	129,276
Operating Segments [Member] \| Better Burgers Fast Casual [Member]
Revenue	5,316,287	5,551,651
Operating Income (Loss):	(169,110)	(68,397)
Depreciation and Amortization	376,631	365,131
Operating Segments [Member] \| Just Fresh Fast Casual [Member]
Revenue	1,383,257	1,361,213
Operating Income (Loss):	63,640	(73,208)
Depreciation and Amortization	79,726	75,123
Operating Segments [Member] \| Corporate and Other [Member]
Revenue	24,990	25,000
Operating Income (Loss):	(841,072)	(815,298)
Depreciation and Amortization	$ 843	$ 910